DEF: Clorox Navigates Complexity, Boosts Margins in FY25

Clorox reported resilient fiscal year 2025 performance with gross margin expansion and adjusted EPS growth despite cyberattack impacts and macroeconomic uncertainties, while advancing its IGNITE strategy.

Summary

• Fiscal year 2025 performance reflected resilience amidst complexity, including impacts from the August 2023 cyberattack and macroeconomic/geopolitical uncertainties.
• The company advanced its IGNITE strategy, enhanced its portfolio of leading brands, grew overall market share and organic sales, and delivered gross margin expansion.
• Achieved solid adjusted EPS growth.
• Advanced Enterprise Resource Planning (ERP) system transition in the U.S. and executed sustainability priorities.
• Gross margin expanded by over 200 basis points, returning to pre-pandemic levels, driven by cost-savings and holistic margin management.
• Launched innovations across all major brands, supported by an AI-enabled digital core.
• Completed the divestiture of the Better Health Vitamins, Minerals and Supplements (VMS) business, positioning for more consistent, profitable growth.
• Fiscal year 2025 net sales were $7,104 million, essentially flat compared to $7,093 million in fiscal year 2024.
• Gross margin increased by 220 basis points to 45.2% in fiscal year 2025 from 43.0% in fiscal year 2024.
• Earnings before income taxes were $1,078 million in fiscal year 2025, up from $398 million in fiscal year 2024.
• Diluted net EPS increased by 190% to $6.52 in fiscal year 2025 from $2.25 in fiscal year 2024.
• Economic Profit (EP) increased by $183 million to $756 million in fiscal year 2025 from $573 million in fiscal year 2024.
• Net cash provided by operations was $981 million in fiscal year 2025, up from $695 million in fiscal year 2024.
• Free cash flow was $761 million (10.7% of net sales) in fiscal year 2025, compared to $483 million (6.8% of net sales) in fiscal year 2024.
• Paid $602 million in cash dividends in fiscal year 2025, with a 2% increase in quarterly dividend announced in July 2025.
• The short-term incentive plan payout for fiscal year 2025 was 80% of target, driven by net customer sales below target, strong gross margin, and solid net earnings.
• The long-term incentive plan (PSUs for FY2022-2024) paid out at 133% of target, reflecting two years above and one year below maximum performance levels for Economic Profit growth.

Sentiment

Score: 8

Explanation: The company demonstrated strong financial recovery and strategic execution in fiscal year 2025, with significant increases in gross margin, EPS, EP, and free cash flow, and a high long-term incentive payout. Strategic divestitures and ERP advancements are positive. However, net sales were flat, and short-term sales targets were missed, with management acknowledging a volatile and challenging operating environment ahead.

Positives

• Demonstrated resilient performance in fiscal year 2025 despite external challenges.
• Gross margin expanded by 220 basis points to 45.2%, returning to pre-pandemic levels.
• Achieved solid adjusted EPS growth, with diluted net EPS increasing by 190% to $6.52.
• Grew overall market share and organic sales.
• Successfully completed the divestiture of the Better Health VMS business, aligning with strategic portfolio evolution for profitable growth.
• Advanced Enterprise Resource Planning (ERP) system transition in the U.S. following successful implementation in Canada.
• Economic Profit (EP) increased by $183 million to $756 million in fiscal year 2025.
• Net cash provided by operations increased to $981 million in fiscal year 2025.
• Free cash flow improved significantly to $761 million (10.7% of net sales) in fiscal year 2025.
• Increased quarterly dividend by 2% in July 2025.
• Long-term incentive plan (PSUs for FY2022-2024) paid out at 133% of target, indicating strong multi-year performance.
• Strengthened Board oversight with five new directors over three years, enhancing expertise in consumer goods, finance, and global operations.
• Maintained strong credit ratings (S&P A-2/BBB+, Moody's P-2/Baa1).

Negatives

• Net customer sales were below target for the fiscal year 2025 short-term incentive plan.
• Categories slowed, competition increased, and consumer behavior shifted in the second half of fiscal year 2025, impacting market share progress and sales growth.
• Navigated remaining impacts from the August 2023 cyberattack.
• Macroeconomic and geopolitical uncertainties continue to create a volatile and challenging operating environment.
• Higher trade promotion spending, unfavorable mix, and higher manufacturing and logistics costs partially offset gross margin gains.
• Incurred a loss on divestiture of $118 million for the Better Health VMS business in fiscal year 2025.
• Expected year-over-year sales reduction in fiscal year 2026 due to retailers drawing down inventory placed in advance of the ERP transition.

Risks

• Unfavorable general economic and geopolitical conditions, including inflation, supply chain disruptions, labor shortages, wage pressures, fuel and energy costs, interest rate fluctuations, foreign currency exchange rate fluctuations, weather events or natural disasters, disease outbreaks or pandemics, terrorism, and unstable geopolitical conditions (e.g., Middle East, Ukraine, China-Taiwan tensions).
• Impact of market and category declines, and the company's product and geographic mix on its ability to meet sales growth targets.
• Ability to successfully execute or realize the anticipated benefits of strategic or transformational initiatives, including the ERP transition and the related timing and volume of shipment movement.
• Impact of the changing retail environment, including the growth of alternative retail channels and business models, and changing consumer preferences.
• Intense competition in the company's markets.
• Volatility and increases in the costs of raw materials, energy, transportation, labor, and other necessary supplies or services.
• Supply chain issues, product shortages, and disruptions to the business, as a result of increased supply chain dependencies due to an expanded supplier network and a reliance on certain single-source suppliers.
• Risks related to the company's use of and reliance on information technology systems, including potential and actual security breaches, cyberattacks, privacy breaches or data breaches that result in the unauthorized disclosure of consumer, customer, employee or company information, business, service or operational disruptions, or that impact the company's financial results or financial reporting, or any resulting unfavorable outcomes, increased costs or legal proceedings.
• Ability to innovate and to develop and introduce commercially successful products, or expand into adjacent categories and countries.
• Ability to successfully manage global political, legal, tax, and regulatory risks, including due to regulatory uncertainty and lack of regulatory convergence among different jurisdictions.
• Lower revenue, increased costs, other financial statement impacts or reputational harm resulting from government actions, compliance with regulations, or any material costs imposed by changes in regulation.
• Ability to maintain its business reputation and the reputation of its brands and products.
• Dependence on key customers and risks related to customer consolidation and ordering patterns.
• Ability to attract and retain key personnel, which may continue to be impacted by challenges in the labor market, such as increasing labor costs and sustained labor shortages.
• Changes to the company's processes and procedures as a result of its digital capabilities and productivity enhancements that may result in changes to the company's internal controls over financial reporting.
• Risks related to the acquisition of P&G's interest in the Glad business.
• Risks related to international operations and international trade, including changing macroeconomic conditions, volatile commodity prices, foreign currency fluctuations, governmental policies, labor claims, civil unrest, military conflicts, and potential negative impact and liabilities from the use, storage and transportation of chlorine.
• Impact of climate change and other sustainability issues on sales, operating costs, reputation or stakeholder relationships.
• Impact of product liability claims, labor claims and other legal, governmental or tax proceedings, including in foreign jurisdictions and in connection with any product recalls.
• Risks relating to acquisitions, new ventures and divestitures, and associated costs, including for asset impairment charges related to, among others, intangible assets, including trademarks and goodwill; and the ability to complete announced transactions and, if completed, integration costs and potential contingent liabilities related to those transactions.
• Accuracy of the company's estimates and assumptions on which its financial projections, including any sales or earnings guidance or outlook it may provide from time to time, are based.
• Risks related to the company's reliance on third-party service providers, including inability to meet cost savings or efficiencies, business or systems disruptions, and other liabilities, including legal or regulatory risk.
• Environmental matters, including costs associated with the remediation and monitoring of past contamination, and possible increases in costs resulting from actions by relevant regulators, and the handling and/or transportation of hazardous substances.
• Ability to effectively utilize, assert and defend its intellectual property rights, and any infringement or claimed infringement by the company of third-party intellectual property rights.
• Effect of the company's indebtedness and credit rating on its business operations and financial results and the company's ability to access capital markets and other funding sources, as well as the cost of capital to the company.
• Ability to pay and declare dividends or repurchase its stock in the future.
• Impacts of potential stockholder activism.

Future Outlook

The fiscal year 2026 plan sets a strong foundation for new, scalable innovation platforms to reinvigorate category growth and drive solid margin and earnings performance. The operating environment is anticipated to remain volatile and challenging, with consumers facing greater pressure due to macroeconomic uncertainty impacting spending. A year-over-year sales reduction is expected in fiscal year 2026 as retailers draw down inventory placed in advance of the ERP transition. Long-term financial goals under the IGNITE strategy include annual net sales growth of 3% to 5%, annual adjusted EBIT margin expansion of 25 to 50 basis points, and annual free cash flow as a percentage of net sales of 11% to 13%. The total incremental transformational investment in ERP and other digital technologies is expected to be $570 to $580 million by fiscal year 2026, generating long-term efficiencies.

Management Comments

• Linda Rendle (Chair and CEO): "Our fiscal year 2025 performance reflected resilience in the face of complexity, as we continued to advance our IGNITE strategy while navigating the remaining impacts from the August 2023 cyberattack and macroeconomic and geopolitical uncertainties."
• Linda Rendle (Chair and CEO): "Fueled by our IGNITE strategy and guided by our values, I believe we are taking the right steps to position Clorox for the future — advancing to be more consumer-obsessed, faster, and leaner."
• Linda Rendle (Chair and CEO): "Our fiscal year 2026 plan sets a strong foundation for new, scalable innovation platforms as we reinvigorate category growth and drive solid margin and earnings performance."
• Matthew J. Shattock (Lead Independent Director): "The Board remains focused on overseeing corporate strategy and risk management as Clorox navigates a dynamic and challenging operating environment."
• Matthew J. Shattock (Lead Independent Director): "Clorox’s transformation efforts to evolve its portfolio and transform its ways of working are laying the foundation for long-term growth and enduring shareholder value."

Industry Context

The company operates in a dynamic and challenging environment marked by macroeconomic and geopolitical uncertainties, which continue to pressure consumer spending. The retail landscape is evolving with the growth of alternative channels and changing consumer preferences. Clorox's IGNITE strategy, focusing on innovation, digital transformation, and portfolio evolution (e.g., VMS divestiture), is designed to address these trends and drive long-term profitable growth. The company's emphasis on sustainability governance and supplier engagement programs like Clorox Climate Partners aligns with increasing investor and stakeholder focus on environmental, social, and governance (ESG) factors within the consumer packaged goods industry.

Comparison to Industry Standards

• Clorox aims to compensate non-employee directors at or near the median of its compensation peer group, which consists of other consumer products companies.
• At the time of the May 2025 compensation peer group review, Clorox's market capitalization was at the 48th percentile and its revenue at the 23rd percentile compared to its peer group.
• The executive compensation framework targets total direct compensation competitively relative to the median of the compensation peer group.
• For Total Shareholder Return (TSR) comparisons, the company uses a composite index comprising the Standard & Poor's Household Products Index and the Standard & Poor's Housewares & Specialties Index.
• The executive pay structure, with 90% of CEO compensation and 85% of other Named Executive Officer (NEO) compensation at risk, is designed to align with performance and competitive market practices.

Management Changes

Corporate Governance

Legal Proceedings

• Involved in certain environmental matters, including response actions at various locations, with recorded liabilities totaling $27 million as of June 30, 2025.
• One environmental matter in Alameda County, California, has an estimated liability of $12 million, with potential additional costs up to approximately $28 million over an estimated 30-year period if regulators require different or longer remediation actions.
• Another environmental matter in Dickinson County, Michigan, has a recorded liability of $10 million, where the company is jointly and severally liable for 24.3% of costs. Any additional exposure is not estimable at this time.
• Subject to various legal proceedings, claims, and other loss contingencies, including those related to contractual arrangements, product liability, patents and trademarks, advertising, labor and employment, environmental, health and safety, and other matters.
• Management believes the ultimate disposition of these legal matters, to the extent not previously provided for, will not have a material adverse effect on the consolidated financial statements.

Related Party Transactions

• Holds various equity investments with ownership percentages of up to 50% in consumer products businesses, presented in Other assets at $47 million as of June 30, 2025.
• Transactions with equity investees primarily represent payments for contract manufacturing and purchases of raw materials, totaling $78 million in fiscal year 2025.
• Has a Venture Agreement with The Procter & Gamble Company (P&G) for the Glad bags and wraps business, where P&G holds a 20% interest. The company pays a royalty to P&G for its interest in profits, losses, and cash flows, which is included in Cost of products sold.
• The company is required to purchase P&G's 20% interest in the Glad business for cash at fair value upon termination of the agreement in January 2026, with an estimated fair value of $476 million as of June 30, 2025, reclassified to Accounts payable and accrued liabilities.

Stakeholder Impact

• Shareholders: Positive impact from increased EPS, gross margin expansion, improved free cash flow, increased dividends, and strong long-term incentive payouts. Board refreshment and strong governance aim to enhance long-term shareholder value.
• Employees: Engagement through global town halls and employee surveys. Focus on fostering a 'People First Culture' and building skills/culture for efficiency. Executive compensation program designed to attract, retain, and motivate talent. Retirement plans and benefits are provided.
• Customers: Innovations across major brands, personalization strategy, and advertising aim to reinforce trust and relevance. ERP transition and streamlined operating model are expected to lead to more efficient and consumer-centered ways of working.
• Suppliers: Clorox Climate Partners program targets emissions-intensive suppliers to facilitate climate action, enhance energy efficiency, and reduce costs. A voluntary supply chain financing program is offered to suppliers.
• Creditors: Strong financial condition and liquidity, with access to capital markets and strong credit ratings (S&P A-2/BBB+, Moody's P-2/Baa1). A new $1,200 million revolving credit agreement is in place.

Next Steps

• Elect 11 director nominees at the Annual Meeting on November 19, 2025.
• Hold an advisory vote to approve executive compensation at the Annual Meeting.
• Ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2026.
• Continue to advance the IGNITE strategy, focusing on reinvigorating category growth and driving solid margin and earnings performance in fiscal year 2026.
• Implement the Enterprise Resource Planning (ERP) system in the U.S. in fiscal year 2026.
• Reassess sustainability priorities in light of evolving external factors and a refreshed materiality assessment.
• Wind down the Venture Agreement with The Procter & Gamble Company for the Glad bags and wraps business by January 31, 2026, and acquire P&G's 20% interest.
• The Management Development and Compensation Committee (MDCC) will continue to evaluate incentive plan changes for fiscal year 2026 based on competitive market evolution and Clorox's long-term transformational business plan.
• The Board plans to continue engaging a third-party evaluation facilitator periodically for board, committee, and director evaluation processes.
• Director compensation changes, including increases to annual director cash retainer, annual DSU grant, NGCRC chair retainer, and MDCC chair retainer, will be effective October 2025.
• Continue to invest in brands, capabilities, and people to deliver consistent, profitable growth over time.

Key Dates

Recommendation

The filing demonstrates strong financial recovery and strategic execution, with significant improvements in key profitability and cash flow metrics (190% EPS growth, 220 basis points gross margin expansion, substantial free cash flow increase). The successful divestiture of the VMS business and ongoing digital transformation efforts (ERP) align with a clear strategy for long-term profitable growth. While net sales were flat and some short-term sales targets were missed, the overall trajectory and management's proactive measures to navigate a challenging environment suggest a positive outlook for sustained value creation. The increased dividend and strong long-term incentive payouts further reinforce confidence in the company's performance and commitment to shareholders.

Keywords

Consumer Packaged Goods, Household Products, Personal Care, Financial Results, SEC Filing, Proxy Statement, Corporate Governance, Executive Compensation, Risk Management, Sustainability, Digital Transformation, ERP System, Divestiture, Gross Margin, EPS Growth, Cash Flow, Shareholder Value, Clorox